JPRN-UMIN000052937尚未招募未知
Optimal antithyroid medication dosage reduction for patients with moderate to severe Graves' disease - Optimal antithyroid medication dosage reduction for patients with moderate to severe Graves' disease
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with untreated Graves' disease who plan to attend a facility participating in this study will be included. (1) Pregnant women, lactating women, and patients who plan to become pregnant within 2 years (2) Patients with untreated Graves' disease who may have thyroid crisis (3) Patients who have received curative treatment for Graves' disease (surgery, intra-iodine radioiodine therapy) in the past (4) Patients receiving immunosuppressive therapy or drugs that affect thyroid function (amiodarone, lithium carbonate, immune checkpoint drugs) (5) Other patients deemed inappropriate as research subjects by the principal investigator.
研究者
相似试验
进行中（未招募）
1 期
A patient guided dose reduction strategy of tyrosine kinase inhibitors in chronic myeloid leukaemiaChronic myeloid leukaemiaMedDRA version: 20.0Level: HLTClassification code 10024296Term: Leukaemias chronic myeloidSystem Organ Class: 100000004851EUCTR2021-006581-20-NLRadboud univeristy medical centre106
已完成
4 期
Efficacy of once weekly thyroxine treatment for poorly controlled hypothyroid patientsCTRI/2017/06/008855State board of Medical Research34
进行中（未招募）
不适用
Optimal prescribing of levothyroxine for underactive thyroid gland treatmentNutritional, Metabolic, EndocrineHypothyroidismISRCTN65030272ewcastle upon Tyne Hospitals NHS Foundation Trust130
进行中（未招募）
不适用
Substitutive therapy of hypothyroid patients with L-thyroxine (T4) plus T3 sulfate (T3S). A Phase II, open-label, single centre, parallel group study on therapeutic efficacy and tolerability - NDThyroidectomized patients without endogenous hormonal production (Tg<5) in stable substitutive therapy with T4MedDRA version: 9.1Level: LLTClassification code 10021117EUCTR2010-018663-42-ITBRACCO
招募中
3 期
Evaluation of effect of thyroid hormone therapy on prognosis of patients with traumatic brain injuryDiffuse traumatic brain injury.Diffuse traumatic brain injuryS06.2IRCT20130310012776N6Vice chancellor of research. Shiraz University of medical sciences266